<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CaPP3 study &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/capp3-study/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 09 Oct 2026 01:27:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CaPP3 study &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Fewer Than One in Ten Lynch Syndrome Patients Use Aspirin to Prevent Colorectal Cancer</title>
		<link>https://bioengineer.org/fewer-than-one-in-ten-lynch-syndrome-patients-use-aspirin-to-prevent-colorectal-cancer/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 09 Oct 2026 01:27:07 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[Cancer prevention]]></category>
		<category><![CDATA[CAPP2 study]]></category>
		<category><![CDATA[CaPP3 study]]></category>
		<category><![CDATA[chemoprevention]]></category>
		<category><![CDATA[Colorectal cancer]]></category>
		<category><![CDATA[genetic predisposition]]></category>
		<category><![CDATA[implementation gap]]></category>
		<category><![CDATA[Lynch syndrome]]></category>
		<category><![CDATA[mRNA cancer vaccine]]></category>
		<category><![CDATA[patient survey]]></category>
		<category><![CDATA[University Hospital Bonn]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=409036</guid>

					<description><![CDATA[A German survey of 539 people with Lynch syndrome found that despite strong evidence that daily aspirin reduces colorectal cancer risk and high patient openness to new prevention, fewer than one in ten take the drug for cancer prevention.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">409036</post-id>	</item>
	</channel>
</rss>
